SCHEMBL13437166

SCHEMBL13437166

O=C(NC1c2ccccc2-c2c(-c3nc4ccncc4[nH]3)cccc21)c1ccncc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 5/20 1.00
PDE5A O76074 3/20 0.44
HPSE Q9Y251 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
METAP2 P50579 1/20 0.40
METAP1 P53582 1/20 0.40
GAA P10253 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
APLNR P35414 1/20 0.38
HTT P42858 1/20 0.38
KDM4E B2RXH2 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13437167 0.92 HSP90AB1 (0.85) HSP90AB1PDE5AHPSEMEN1KMT2A
SCHEMBL13437192 0.91 HSP90AB1 (0.83) HSP90AB1PDE5AHPSEMEN1KMT2A
SCHEMBL13437169 0.90 HSP90AB1 (0.81) HSP90AB1PDE5AHPSEMEN1KMT2A
SCHEMBL13437201 0.89 HSP90AB1 (0.81) HSP90AB1PDE5AHPSEMEN1KMT2A
SCHEMBL13437209 0.89 HSP90AB1 (0.81) HSP90AB1PDE5AHPSEMEN1KMT2A
SCHEMBL12430429 0.89 HSP90AB1 (1.00) HSP90AB1PDE5AHPSEMETAP2METAP1
SCHEMBL13437204 0.89 HSP90AB1 (0.81) HSP90AB1PDE5AHPSESMN1; SMN2METAP2
SCHEMBL13437213 0.89 HSP90AB1 (0.81) HSP90AB1PDE5AHPSEMEN1KMT2A
SCHEMBL13437218 0.89 HSP90AB1 (0.80) HSP90AB1PDE5AMEN1KMT2AMETAP2
SCHEMBL12431609 0.89 HSP90AB1 (0.79) HSP90AB1PDE5AHPSEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 HSP90AB1 2/4885PDE5A 2779/4885HPSE 3194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.